XML 26 R12.htm IDEA: XBRL DOCUMENT v3.4.0.3
Financial Instruments and Derivatives
3 Months Ended
Apr. 03, 2016
Financial Instruments and Derivatives

E. Financial Instruments and Derivatives

Cash Equivalents

Teradyne considers all highly liquid investments with maturities of three months or less at the date of acquisition to be cash equivalents.

Marketable Securities

Teradyne accounts for its investments in debt and equity securities in accordance with the provisions of Accounting Standards Codification (“ASC”) 320-10, “Investments—Debt and Equity Securities.” ASC 320-10 requires that certain debt and equity securities be classified into one of three categories; trading, available-for-sale or held-to-maturity securities. As of April 3, 2016, Teradyne’s investments in debt and equity securities were classified as available-for-sale and recorded at their fair market value.

On a quarterly basis, Teradyne reviews its investments to identify and evaluate those that have an indication of a potential other-than-temporary impairment. Factors considered in determining whether a loss is other-than-temporary include:

 

    The length of time and the extent to which the market value has been less than cost;

 

    The financial condition and near-term prospects of the issuer; and

 

    The intent and ability to retain the investment in the issuer for a period of time sufficient to allow for any anticipated recovery in market value.

Teradyne uses the market and income approach techniques to value its financial instruments and there were no changes in valuation techniques during the three months ended April 3, 2016. As defined in ASC 820-10, “Fair Value Measurements and Disclosures,” fair value is the price that would be received from the sale of an asset or paid to transfer a liability in an orderly transaction between market participants. ASC 820-10 requires that assets and liabilities carried at fair value be classified and disclosed in one of the following three categories:

Level 1: Quoted prices in active markets for identical assets as of the reporting date;

Level 2: Inputs other than Level 1, that are observable either directly or indirectly as of the reporting date. For example, a common approach for valuing fixed income securities is the use of matrix pricing. Matrix pricing is a mathematical technique used to value securities by relying on the securities’ relationship to other benchmark quoted prices, and is considered a Level 2 input; or

Level 3: Unobservable inputs that are not supported by market data. Unobservable inputs are developed based on the best information available, which might include Teradyne’s own data.

Teradyne’s available-for-sale debt and equity securities are classified as Level 1 and Level 2. Acquisition-related contingent consideration is classified as Level 3. Teradyne’s contingent consideration is valued using a Monte Carlo simulation model or a probability weighted discounted cash flow model. The majority of Level 2 securities are fixed income securities priced by third party pricing vendors. These pricing vendors utilize the most recent observable market information in pricing these securities or, if specific prices are not available, use other observable inputs like market transactions involving identical or comparable securities.

Realized gains recorded in the three months ended April 3, 2016 and April 5, 2015 were $0.2 million and $0.5 million, respectively. Realized losses recorded in the three months ended April 3, 2016 were $0.2 million. There were no realized losses recorded in the three months ended April 5, 2015. Realized gains are included in interest income and realized losses are included in interest expense. Unrealized gains and losses are included in accumulated other comprehensive income (loss). The cost of securities sold is based on the specific identification method.

During the three months ended April 3, 2016 and April 5, 2015, there were no transfers in or out of Level 1, Level 2 or Level 3 financial instruments.

The following table sets forth by fair value hierarchy Teradyne’s financial assets and liabilities that were measured at fair value on a recurring basis as of April 3, 2016 and December 31, 2015.

 

     April 3, 2016  
     Quoted Prices
in Active
Markets for
Identical
Instruments
(Level 1)
     Significant
Other
Observable
Inputs
(Level 2)
     Significant
Unobservable
Inputs
(Level 3)
     Total  
     (in thousands)  

Assets

           

Cash

   $ 227,046       $ —         $ —         $ 227,046   

Cash equivalents

     92,010         302         —           92,312   

Available-for-sale securities:

           

U.S. Treasury securities

     —           399,277         —           399,277   

Corporate debt securities

     —           161,590         —           161,590   

Commercial paper

     —           36,592         —           36,592   

U.S. government agency securities

     —           26,160         —           26,160   

Certificates of deposit and time deposits

     —           15,653         —           15,653   

Equity and debt mutual funds

     16,369         —           —           16,369   

Non-U.S. government securities

     —           434         —           434   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 335,425       $ 640,008       $ —         $ 975,433   
  

 

 

    

 

 

    

 

 

    

 

 

 

Liabilities

           

Contingent consideration

   $ —         $ —         $ 23,609       $ 23,609   

Derivative liabilities

     —           193         —           193   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ —         $ 193       $ 23,609       $ 23,802   
  

 

 

    

 

 

    

 

 

    

 

 

 

 

Reported as follows:

 

     (Level 1)      (Level 2)      (Level 3)      Total  
     (in thousands)  

Assets

           

Cash and cash equivalents

   $ 319,056       $ 302       $ —         $ 319,358   

Marketable securities

     —           410,003         —           410,003   

Long-term marketable securities

     16,369         229,703         —           246,072   
  

 

 

    

 

 

    

 

 

    

 

 

 
   $ 335,425       $ 640,008       $ —         $ 975,433   
  

 

 

    

 

 

    

 

 

    

 

 

 

Liabilities

           

Other current liabilities

   $ —         $ 193       $ —         $ 193   

Contingent consideration

     —           —           500         500   

Long-term contingent consideration

     —           —           23,109         23,109   
  

 

 

    

 

 

    

 

 

    

 

 

 
   $ —         $ 193       $ 23,609       $ 23,802   
  

 

 

    

 

 

    

 

 

    

 

 

 

 

     December 31, 2015  
     Quoted Prices
in Active
Markets for
Identical
Instruments
(Level 1)
     Significant
Other
Observable
Inputs
(Level 2)
     Significant
Unobservable
Inputs
(Level 3)
     Total  
     (in thousands)  

Assets

           

Cash

   $ 213,336       $ —         $ —         $ 213,336   

Cash equivalents

     49,241         2,128         —           51,369   

Available for sale securities:

           

U.S. Treasury securities

     —           419,958         —           419,958   

Corporate debt securities

     —           161,634         —           161,634   

U.S. government agency securities

     —           83,952         —           83,952   

Certificates of deposit and time deposits

     —           43,394         —           43,394   

Commercial paper

     —           20,308         —           20,308   

Equity and debt mutual funds

     13,954         —           —           13,954   

Non-U.S. government securities

     —           424         —           424   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 276,531       $ 731,798       $ —         $ 1,008,329   

Derivative assets

     —           109         —           109   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 276,531       $ 731,907       $ —         $ 1,008,438   
  

 

 

    

 

 

    

 

 

    

 

 

 

Liabilities

           

Contingent consideration

   $ —         $ —         $ 37,436       $ 37,436   

Derivative liabilities

     —           146         —           146   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ —         $ 146       $ 37,436       $ 37,582   
  

 

 

    

 

 

    

 

 

    

 

 

 

 

Reported as follows:

 

     (Level 1)      (Level 2)      (Level 3)      Total  
     (in thousands)  

Assets

           

Cash and cash equivalents

   $ 262,577       $ 2,128       $ —         $ 264,705   

Marketable securities

     —           477,696         —           477,696   

Long-term marketable securities

     13,954         251,974         —           265,928   

Prepayments

     —           109         —           109   
  

 

 

    

 

 

    

 

 

    

 

 

 
   $ 276,531       $ 731,907       $ —         $ 1,008,438   
  

 

 

    

 

 

    

 

 

    

 

 

 

Liabilities

           

Other current liabilities

   $ —         $ 146       $ —         $ 146   

Contingent consideration

     —           —           15,500         15,500   

Long-term contingent consideration

     —           —           21,936         21,936   
  

 

 

    

 

 

    

 

 

    

 

 

 
   $ —         $ 146       $ 37,436       $ 37,582   
  

 

 

    

 

 

    

 

 

    

 

 

 

Changes in the fair value of Level 3 contingent consideration for the three months ended April 3, 2016 and April 5, 2015 were as follows:

 

     For the Three Months
Ended
 
     April 3,
2016
     April 5,
2015
 
     (in thousands)  

Balance at beginning of period

   $ 37,436       $ 3,350   

Payments (a)

     (15,000      —     

Fair value adjustment (b)

     1,173         —     
  

 

 

    

 

 

 

Balance at end of period

   $ 23,609       $ 3,350   
  

 

 

    

 

 

 

 

(a) In the three months ended April 3, 2016, based on Universal Robots’ calendar year 2015 EBITDA results, Teradyne paid $15 million or 100% of the eligible EBITDA contingent consideration amount.
(b) In the three months ended April 3, 2016, the fair value of contingent consideration for the earn-out in connection with the acquisition of Universal Robots was increased by $1.2 million primarily due to a lower discount rate.

The following table provides quantitative information associated with the fair value measurement of Teradyne’s Level 3 financial instruments:

 

Liability

  April 3,
2016
Fair Value
  Valuation
Technique
 

Unobservable Inputs

  Weighted
Average
 
    (in thousands)              

Contingent consideration

(Universal Robots)

  $16,349   Monte Carlo
Simulation
  Revenue for the period July 1, 2015—December 31, 2017 volatility     15.4
      Discount Rate     4.7
       
  $6,760   Monte Carlo
Simulation
  Revenue for the period July 1, 2015—December 31, 2018 volatility     15.4
      Discount Rate     4.7

Contingent consideration

(AIT)

  $500   Income approach-
discounted cash
flow
 

Revenue for calendar year 2016 probability

Discount rate

   

 

48

4.7


 

As of April 3, 2016, the significant unobservable inputs used in the Monte Carlo simulation to fair value the Universal Robots contingent consideration include forecasted revenue, revenue volatility and discount rate. Increases or decreases in the inputs would result in a higher or lower fair value measurement. The maximum payment for each of the two Universal Robots revenue earn-outs is $25.0 million.

The significant unobservable inputs used in the Avionics Interface Technology, LLC (“AIT”) fair value measurement of contingent consideration are the probabilities of successful achievement of calendar year 2016 revenue threshold and target, and a discount rate. Increases or decreases in the revenue probabilities would result in a higher or lower fair value measurement. The maximum payment for the AIT earn-out is $1.1 million.

The carrying amounts and fair values of Teradyne’s financial instruments at April 3, 2016 and December 31, 2015 were as follows:

 

     April 3, 2016      December 31, 2015  
     Carrying Value      Fair Value      Carrying Value      Fair Value  
     (in thousands)  

Assets

           

Cash and cash equivalents

   $ 319,358       $ 319,358       $ 264,705       $ 264,705   

Marketable securities

     656,075         656,075         743,624         743,624   

Derivative assets

     —           —           109         109   

Liabilities

           

Contingent consideration

     23,609         23,609         37,436         37,436   

Derivative liabilities

     193         193         146         146   

The fair values of accounts receivable, net and accounts payable approximate the carrying value due to the short-term nature of these instruments.

The following tables summarize the composition of available-for-sale marketable securities at April 3, 2016 and December 31, 2015:

 

     April 3, 2016  
    

 

Available-for-Sale

     Fair Market
Value of
Investments
with Unrealized
Losses
 
     Cost      Unrealized
Gain
     Unrealized
(Loss)
    Fair Market
Value
    
     (in thousands)  

U.S. Treasury securities

   $ 398,832       $ 620       $ (175   $ 399,277       $ 204,136   

Corporate debt securities

     161,005         1,861         (1,276     161,590         73,165   

Commercial paper

     36,563         29         —          36,592         6,475   

U.S. government agency securities

     26,107         57         (4     26,160         9,747   

Equity and debt mutual funds

     15,110         1,328         (69     16,369         746   

Certificates of deposit and time deposits

     15,651         2         —          15,653         —     

Non-U.S. government securities

     434         —           —          434         —     
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 
   $ 653,702       $ 3,897       $ (1,524   $ 656,075       $ 294,269   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 

 

Reported as follows:

 

     Cost      Unrealized
Gain
     Unrealized
(Loss)
    Fair Market
Value
     Fair Market
Value of
Investments
with Unrealized
Losses
 
     (in thousands)  

Marketable securities

   $ 409,971       $ 146       $ (114   $ 410,003       $ 204,024   

Long-term marketable securities

     243,731         3,751         (1,410     246,072         90,245   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 
   $ 653,702       $ 3,897       $ (1,524   $ 656,075       $ 294,269   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 

 

     December 31, 2015  
    

 

Available-for-Sale

     Fair Market
Value of
Investments
with Unrealized
Losses
 
     Cost      Unrealized
Gain
     Unrealized
(Loss)
    Fair Market
Value
    
     (in thousands)  

U.S. Treasury securities

   $ 421,060       $ 65       $ (1,167   $ 419,958       $ 379,434   

Corporate debt securities

     163,297         902         (2,565     161,634         145,373   

U.S. government agency securities

     84,032         42         (122     83,952         55,120   

Certificates of deposit and time deposits

     43,391         6         (3     43,394         10,527   

Commercial paper

     20,298         11         (1     20,308         8,646   

Equity and debt mutual funds

     12,996         1,119         (161     13,954         2,560   

Non-U.S. government securities

     424         —           —          424         —     
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 
   $ 745,498       $ 2,145       $ (4,019   $ 743,624       $ 601,660   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 

Reported as follows:

 

     Cost      Unrealized
Gain
     Unrealized
(Loss)
    Fair Market
Value
     Fair Market
Value of
Investments
with Unrealized
Losses
 
     (in thousands)  

Marketable securities

   $ 478,306       $ 38       $ (648   $ 477,696       $ 374,785   

Long-term marketable securities

     267,192         2,107         (3,371     265,928         226,875   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 
   $ 745,498       $ 2,145       $ (4,019   $ 743,624       $ 601,660   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 

As of April 3, 2016, the fair market value of investments with unrealized losses totaled $294.3 million. Of this value, $2.8 million had unrealized losses of $0.5 million greater than one year and $291.5 million had unrealized losses of $1.1 million for less than one year.

As of December 31, 2015, the fair market value of investments with unrealized losses totaled $601.7 million. Of this value, $0.9 million had unrealized losses of $0.5 million greater than one year and $600.8 million had unrealized losses of $3.6 million for less than one year.

Teradyne reviews its investments to identify and evaluate investments that have an indication of possible impairment. Based on this review, Teradyne determined that the unrealized losses related to these investments, at April 3, 2016 and December 31, 2015, were temporary.

 

The contractual maturities of investments held at April 3, 2016 were as follows:

 

     April 3, 2016  
     Cost      Fair Market
Value
 
     (in thousands)  

Due within one year

   $ 409,971       $ 410,003   

Due after 1 year through 5 years

     184,645         184,852   

Due after 5 years through 10 years

     4,432         4,546   

Due after 10 years

     39,544         40,305   
  

 

 

    

 

 

 

Total

   $ 638,592       $ 639,706   
  

 

 

    

 

 

 

Contractual maturities of investments held at April 3, 2016 exclude equity and debt mutual funds as they do not have contractual maturity dates.

Derivatives

Teradyne conducts business in a number of foreign countries, with certain transactions denominated in local currencies. The purpose of Teradyne’s foreign currency management is to minimize the effect of exchange rate fluctuations on certain foreign currency denominated monetary assets and liabilities. Teradyne does not use derivative financial instruments for trading or speculative purposes.

To minimize the effect of exchange rate fluctuations associated with the remeasurement of monetary assets and liabilities denominated in foreign currencies, Teradyne enters into foreign currency forward contracts. The change in fair value of these derivatives is recorded directly in earnings, and is used to offset the change in value of monetary assets and liabilities denominated in foreign currencies.

The notional amount of foreign currency forward contracts was $138.5 million and $114.1 million at April 3, 2016 and December 31, 2015, respectively. The fair value of the outstanding contracts was a loss of $0.2 million and $0.0 million at April 3, 2016 and December 31, 2015, respectively.

For the three months ended April 3, 2016 and April 5, 2015, Teradyne recorded net realized losses of $3.3 million and $3.4 million, respectively, related to foreign currency forward contracts hedging net monetary positions. Gains and losses on foreign currency forward contracts and foreign currency remeasurement gains and losses on monetary assets and liabilities are included in other (income) expense, net.

The following table summarizes the fair value of derivative instruments at April 3, 2016 and December 31, 2015:

 

     Balance Sheet Location    April 3,
2016
    December 31,
2015
 
          (in thousands)  

Derivatives not designated as hedging instruments:

       

Foreign exchange contracts assets

   Prepayments    $ —        $ 109   

Foreign exchange contracts liabilities

   Other current liabilities      (193     (146
     

 

 

   

 

 

 

Total derivatives

      $ (193   $ (37
     

 

 

   

 

 

 

Teradyne’s foreign exchange contracts are subject to master netting agreements.

 

The following table summarizes the effect of derivative instruments recognized in the statement of operations during the three months ended April 3, 2016 and April 5, 2015. The table does not reflect the corresponding gains and losses from the remeasurement of monetary assets and liabilities denominated in foreign currencies. For the three months ended April 3, 2016 and April 5, 2015, net gains from the remeasurement of monetary assets and liabilities denominated in foreign currencies were $3.4 million and $4.3 million, respectively.

 

     Location of (Gains) Losses
Recognized in

Statement
of Operations
       For the Three Months    
Ended
 
      April 3,
2016
     April 5,
2015
 
          (in thousands)  

Derivatives not designated as hedging instruments:

        

Foreign exchange contracts

   Other (income) expense, net    $ 3,298       $ 3,425   
     

 

 

    

 

 

 

Total Derivatives

      $ 3,298       $ 3,425